Table 4.
System performance on the application set in which the patients received coronary artery bypass graft surgery
| Coronary artery bypass grafting | Positive | Total | Percentage (by system) | |
| Measure 3 | ACE inhibitors/angiotensin receptor blockers before discharge (poor left ventricular ejection fraction) | 4 | 26 | 15.4 |
| Measure 4 | Aspirin before discharge | 426 | 589 | 72.3 |
| Measure 5 | β-blockers before discharge | 141 | 562 | 25.1 |
| Measure 6 | Statin before discharge | 27 | 589 | 4.6 |
| Complications | Types | Percentage | ||
| Hypotension/shock | 19.0 | |||
| Atrial fibrillation | 10.7 | |||
| Pulmonary edema | 8.0 | |||
| Bradycardia | 6.4 | |||
| Pneumonia | 4.9 | |||
| Ventricular septal defect | 3.4 | |||
| Asystole | 1.0 | |||
| Cardiac tamponade | 0.7 | |||
| Case death | Elective+emergent surgery | 8.7 |